FDA Legislative Updates, In Brief
Pandemic flu: Federal preparations for and response to the H1N1 flu outbreak is funded with $7.7 billion in the 2009 supplemental appropriations bill approved by House and Senate conferees June 11. The funds are allotted to HHS, but most - $5.8 billion - will be available only on a contingency basis for critical needs. The remaining $1.85 billion, the amount provided by the original House bill and $350 million more than by the Senate bill, will be immediately available. Bill language has not been released yet, but a House staffer said the money will be divvied up according to earlier House language, which allowed financing of private vaccine production facility construction or rehabilitation (1"The Pink Sheet," May 25, 2009, p. 32). The White House requested the contingency funds June 2; final House and Senate approval on the consensus measure is expected shortly. The agreement came the same day as the World Health Organization announced that the spread of the H1N1 virus meets criteria for an influenza pandemic
You may also be interested in...
Agency to receive $170 million for regulatory sciences initiative in recognition of the need for smother development pathway for medical countermeasures.
Federal coffers could be tapped to pay for construction or rehabilitation of privately owned vaccine production facilities under a supplemental appropriations bill passed by the House May 14
A $166 million initiative aimed at ensuring supply chain safety and security for medical products is part of the $3.2 billion fiscal year 2010 FDA budget proposed by the Obama administration